Simulation-informed Modelling and Personalized Evaluation (SIMPLE) in Ageing Populations
1 other identifier
observational
300
1 country
1
Brief Summary
Multimodal magnetic resonance imaging (MRI), detecting brain structural and functional changes, has emerged as a powerful and promising technique to study individual's brain, as T1-weighted scans can detect morphometric features, diffusion tensor imaging (DTI) scans can quantify structural connectivity, and functional MRI can capture the features of functional connectivity. Notably, with the advances in quantitative methods, computational models of brain age and brain-predicted age difference (brain-PAD) detecting the ageing effects on individual's brain features are becoming increasingly popular in clinical studies, which might revolutionize the diagnostic and prognostic phonotypes of age-related brain diseases globally.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 25, 2024
CompletedFirst Posted
Study publicly available on registry
August 27, 2024
CompletedStudy Start
First participant enrolled
January 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
January 14, 2025
January 1, 2025
1.7 years
August 25, 2024
January 11, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Estimated brain age
Using the structural and functional connectivity, individual's brain age is calculated based on the connectivity features of core brain networks.
Baseline
Cognitive maintenance
The dynamic change of cognitive status is used to evaluate cognitive maintenance. The performance of global cognition is used to determine the cognitive status, including mild neurocognitive disorder (NCD) and major NCD. The global cognition is measured by mini-mental state examination (MMSE).
Baseline
Plasma β-amyloid
The levels of Aβ42 and Aβ40 in the plasma samples will be quantified by enzyme-linked immunosorbent assay.
Baseline
Secondary Outcomes (4)
Brain-predicted age difference (brain-PAD)
Baseline
Complex attention
Baseline
Memory and learning
Baseline
Executive function
Baseline
Eligibility Criteria
Ageing adults and adults with sleep disturbances.
You may qualify if:
- Chinese old adults are the ones who are over 60 years of chronological age.
- Sleep disturbance: individual's subjective sleep quality is assessed using the Pittsburgh Sleep Quality Index (PSQI) with a total score \>5.
You may not qualify if:
- History of bipolar disorders or psychosis.
- History of major neurological deficits, including stroke, transient ischemic attack or brain tumor.
- Unable to participant magnetic resonance imaging (MRI) scanning.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Tai Po Hospital
Hong Kong, 100000, Hong Kong
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Hanna Lu, PhD
Chinese University of Hong Kong
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
August 25, 2024
First Posted
August 27, 2024
Study Start
January 1, 2025
Primary Completion (Estimated)
August 31, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
January 14, 2025
Record last verified: 2025-01